Beatrice Macchi
1980-1982: Fogarty Fellowship at "Surgical Neurology Branch" NINCDS.
1982-1983: AIRC Fellowship "Tumor Cell Biology", NCI.
1983-1984: "Visiting Associate", NCI, NIH, Bethesda, MD.
1993: " Visiting Scientist" at "Retrovirus Research Center" Dept of Veteran Affairs, Veteran Hospital, Baltimore, MD, USA.
1984: University position as Assistant Professor at the Dept. of Systems Medicine.
2018: Assistant Professor at the Dept. of Chemical Science and Technologies, University of Rome, "Tor Vergata". Coordinator of research. National research program on AIDS.
1997–2001 (I,II,III,IV programs): "Apoptotic cell death in the response to antiretroviral therapy and in the reconstitution of immune system in HIV patients”.
2009 (V and VI programs): “ Development and validation of a new assay for HIV reverse transcriptase inhibition by nucleoside and non-nucleoside RT inhibitors”.
1996-2008: Research projects supported by University of Rome "Tor Vergata".
PRIN:
2005: “Stereoselective synthesis and biological evaluation of compounds focused on antiviral activity”.
2006: “Biological and antiviral activity of new heterocyclic compounds”.
2012-2015: “Design and stereoselective synthesis of compounds active towards protein targets involved in viral and tumor pathologies."
Bibliometric indicators:
SCOPUS: h-index: 24. Documents by author: 108. Total citations: 1739 total.
Short Biography
Beatrice Macchi
1980-1982: Fogarty Fellowship at "Surgical Neurology Branch" NINCDS.
1982-1983: AIRC Fellowship "Tumor Cell Biology", NCI.
1983-1984: "Visiting Associate", NCI, NIH, Bethesda, MD.
1993: " Visiting Scientist" at "Retrovirus Research Center" Dept of Veteran Affairs, Veteran Hospital, Baltimore, MD, USA.
1984: University position as Assistant Professor at the Dept. of Systems Medicine.
2018: Assistant Professor at the Dept. of Chemical Science and Technologies, University of Rome, "Tor Vergata". Coordinator of research. National research program on AIDS.
1997–2001 (I,II,III,IV programs): "Apoptotic cell death in the response to antiretroviral therapy and in the reconstitution of immune system in HIV patients”.
2009 (V and VI programs): “ Development and validation of a new assay for HIV reverse transcriptase inhibition by nucleoside and non-nucleoside RT inhibitors”.
1996-2008: Research projects supported by University of Rome "Tor Vergata".
PRIN:
2005: “Stereoselective synthesis and biological evaluation of compounds focused on antiviral activity”.
2006: “Biological and antiviral activity of new heterocyclic compounds”.
2012-2015: “Design and stereoselective synthesis of compounds active towards protein targets involved in viral and tumor pathologies."
Bibliometric indicators:
SCOPUS: h-index: 24. Documents by author: 108. Total citations: 1739 total.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
